Mark Niciu: Clinical Trials

2 trials sponsored by Mark Niciu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Mark Niciu: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
University of Iowa Interventional Psychiatry Service Patient Registry
Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Ketamine - Treatment Resistant Depression, Major Depressive Episode
RecruitingMark Niciu10002020-11-022026-03-03
Ketamine Alcohol (in Treatment-Resistant Depression)
Ketamine - Magnetic Resonance Imaging, Major Depression
Phase 2RecruitingMark Niciu602014-04-232026-05-01

Conditions studied

Depressive Disorder, Major (2)  ·  Alcoholism (1)  ·  Bipolar Disorder (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Obsessive-Compulsive Disorder (1)

Interventions

Ketamine (2)  ·  Esketamine (1)  ·  Transcranial Magnetic Stimulation (1)

Countries

United States (2)

Top investigators

Mark J Niciu, M.D. Ph.D. (1)  ·  Mark J Niciu, M.D., Ph. D. (1)  ·  Nicholas T Trapp, M.D., M.S. (1)

Results publications

PMID 42171126

NIH funding

R00AA024142 (1)